Aerogen
Manufacturing · Ireland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Galway Business Park Dangan, Galway, Con...Phone Number
+353 91540400Website
www.aerogen.comRevenue
$100.3 MillionIndustry
About Aerogen
Aerogen Org Chart
Is Aerogen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Aerogen has new funding data
Product Launch: Get notified when Aerogen launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Aerogen, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Aerogen recently announced quarterly report
Check if Aerogen has recently received funding, and reach out quickly before it becomes old news!
Click to see if Aerogen had a recent Job posting/layoffs
Check out if Aerogen is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Aerogen
Recommended Actions
Reach out to Masked Content who joined Aerogen as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Aerogen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aerogen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aerogen.
Aerogen Tech Stack
A closer look at the technologies used by Aerogen
Most Recent Scoops
Aerogen News & Media
Aerogen opens headquarters in India to expand respiratory care solutions
Ireland-based medtech company strengthens presence in India with aerosol drug delivery technologyWorld-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen® and CanSinoBIO, First Public Booster Immunization in China.
GALWAY, Ireland--(BUSINESS WIRE)--Late in 2021, Aerogen® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s Recombinant Novel Coronavirus Vaccine Convidecia Air™ utilizing Aerogen’s proprietary aerosol drug delivery technology. In 2022 Convidecia Air™ was granted Emergency Use Authorization as a booster dose by the National Medical Products Administration of China (“NMPA”Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China
SHANGHAI, Dec. 22, 2021 /PRNewswire/ -- Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Nuance Pharma ("Nuance"), a specialty care focused biopharma with late-stage clinical programs and existing commercial operations, today announce an...Aerogen® et CanSinoBIO s'accordent sur un partenariat historique pour le développement et la commercialisation du tout premier vaccin Covid-19 par inhalation au monde
GALWAY, Irlande--(BUSINESS WIRE)--Au terme de plusieurs mois de travaux de développement conjoints, Aerogen® (Galway, Irlande) et CanSinoBIO (SSE : 688185, HKEX : 06185) (Tianjin, Chine) annoncent la signature d'un partenariat de développement et de commercialisation du nouveau vaccin recombinant contre le coronavirus. Le vaccin de CanSinoBIO, Convidecia™, est administré par inhalation grâce à la technologie brevetée d'Aerogen conçue pour l'administration de médicaments par aérosol à mailles vi
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aerogen
Founded in 1997 and Headquartered in Connaught, Ireland. Aerogen company, synonymous with scientific excellence, and has a strong international presence with offices in Ireland, UK, Germany, United States, Middle East and Asia. Aerogen specialises in the design, manufacture and commercialisation of aerosol drug delivery systems. Aerogen's patented... Read More